Janus Kinase (JAK) Inhibitors Global Market Report 2024, Featuring Key Players Pfizer, Merck, AbbVie, Novartis, Sanofi, Bristol Myers Squibb, GSK, Takeda, Eli Lilly and Gilead Sciences

DUBLIN, March 4, 2024 /PRNewswire/ — The “Janus Kinase (JAK) Inhibitors Global Market Report 2024” has been added to ResearchAndMarkets.com’s offering. The latest research on the global Janus Kinase (JAK) inhibitors market underscores a substantial growth trajectory, with an anticipated…